T-BHQ Provides Protection against Lead Neurotoxicity via Nrf2/HO-1 Pathway

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Ye, Fang ^a   Li, Xiaoyi ^a   Li, Lili ^a   Yuan, Jing ^a   Chen, Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELL DEATH; OXIDATIVE STRESS;

DISEASE MODELS; FRONTAL CORTEX; IMMUNOFLUORESCENCE ANALYSIS; NEURONAL APOPTOSIS; NISSL STAINING; NUCLEAR TRANSLOCATIONS; PROTECTIVE EFFECTS; SOD ACTIVITIES;

TOXICITY;

ANTIOXIDANT; CASPASE 3; CASPASE 7; GLUTATHIONE; HEME OXYGENASE 1; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; 2-TERT-BUTYLHYDROQUINONE; HYDROQUINONE DERIVATIVE; LEAD; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; GEL MOBILITY SHIFT ASSAY; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LEAD POISONING; MALE; NEUROPROTECTION; NEUROTOXICITY; NISSL STAINING; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL NUCLEUS; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CELL NUCLEUS; HEME OXYGENASE-1; HIPPOCAMPUS; HUMANS; HYDROQUINONES; LEAD; MALE; NEURONS; NEUROPROTECTION; NEUROTOXINS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN TRANSPORT; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84954306127     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/2075915     Document Type: Article

References (52)

1. L. D. White, D. A. Cory-Slechta, M. E. Gilbert et al., "New and evolving concepts in the neurotoxicology of lead, " Toxicology and Applied Pharmacology, vol. 225, no. 1, pp. 1-27, 2007.
2. H. Needleman, "Lead poisoning, " Annual Review of Medicine, vol. 55, no. 1, pp. 209-222, 2004.
3. T. I. Lidsky and J. S. Schneider, "Lead neurotoxicity in children: basic mechanisms and clinical correlates, " Brain, vol. 126, no. 1, pp. 5-19, 2003.
4. S. J. Yiin and T. H. Lin, "Lead-catalyzed peroxidation of essential unsaturated fatty acid, " Biological Trace Element Research, vol. 50, no. 2, pp. 167-172, 1995.
5. J. M. Matés, "Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology, " Toxicology, vol. 153, no. 1-3, pp. 83-104, 2000.
6. S. J. S. Flora and R. Gupta, "Beneficial effects of Centella asiatica aqueous extract against arsenic-induced oxidative stress and essentialmetal status in rats, " Phytotherapy Research, vol. 21, no. 10, pp. 980-988, 2007.
7. L. Patrick, "Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity, " AlternativeMedicine Review, vol. 11, no. 2, pp. 114-127, 2006.
8. G. Flora, D. Gupta, and A. Tiwari, "Toxicity of lead: a review with recent updates, " Interdisciplinary Toxicology, vol. 5, no. 2, pp. 47-58, 2012.
9. M. G. Shalan, M. S. Mostafa, M. M. Hassouna, S. E. H. El-Nabi, and A. El-Refaie, "Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements, " Toxicology, vol. 206, no. 1, pp. 1-15, 2005.
10. R. C. Patra, D. Swarup, and S. K. Dwivedi, "Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats, " Toxicology, vol. 162, no. 2, pp. 81-88, 2001.
11. L. Seddik, T. M. Bah, A. Aoues, M. Slimani, and M. Benderdour, "Elucidation ofmechanisms underlying the protective effects of olive leaf extract against lead-induced neurotoxicity in Wistar rats, "TheJournal of Toxicological Sciences, vol. 36, no. 6, pp. 797-809, 2011.
12. L. Wang, H. Wang, M. Hu, J. Cao, D. Chen, and Z. Liu, "Oxidative stress and apoptotic changes in primary cultures of rat proximal tubular cells exposed to lead, " Archives of Toxicology, vol. 83, no. 5, pp. 417-427, 2009.
13. S. J. Flora, M. Pande, G. M. Kannan, and A. Mehta, "Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats, " Cellular and Molecular Biology, vol. 50, pp. OL543-OL551, 2004.
14. G. R. Sajitha, R. Jose, A. Andrews, K. G. Ajantha, P. Augustine, and K. T. Augusti, "Garlic oil and vitamin E prevent the adverse effects of lead acetate and ethanol separately as well as in combination in the drinking water of rats, " Indian Journal of Clinical Biochemistry, vol. 25, no. 3, pp. 280-288, 2010.
15. W. Li and A.-N. Kong, "Molecular mechanisms of Nrf2-mediated antioxidant response, " Molecular Carcinogenesis, vol. 48, no. 2, pp. 91-104, 2009.
16. K. Itoh, N. Wakabayashi, Y. Katoh et al., "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, " Genes &Development, vol. 13, no. 1, pp. 76-86, 1999.
17. M. Furukawa and Y. Xiong, "BTB protein keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the cullin 3-Roc1 ligase, " Molecular and Cellular Biology, vol. 25, no. 1, pp. 162-171, 2005.
18. H.-K. Na and Y.-J. Surh, "Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1, " Free Radical Biology and Medicine, vol. 67, pp. 353-365, 2014.
19. M. P. Soares and F. H. Bach, "Heme oxygenase-1: from biology to therapeutic potential, " Trends in Molecular Medicine, vol. 15, no. 2, pp. 50-58, 2009.
20. T. Rangasamy, J. Guo, W. A. Mitzner et al., "Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice, "The Journal of ExperimentalMedicine, vol. 202, no. 1, pp. 47-59, 2005.
21. R. Zhao, B. Yang, L. Wang et al., "Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 412576, 11 pages, 2013.
22. J. Xu, H. Wang, K. Ding et al., "Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway, " Free Radical Biology and Medicine, vol. 71, pp. 186-195, 2014.
23. E. M. Messier, K. Bahmed, R. M. Tuder, H. W. Chu, R. P. Bowler, and B. Kosmider, "Trolox contributes toNrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke, " Cell Death and Disease, vol. 4, no. 4, article 573, 2013.
24. C. Yang, X. Zhang, H. Fan, and Y. Liu, "Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia, " Brain Research, vol. 1282, pp. 133-141, 2009.
25. T. H. Rushmore and A.-N. T. Kong, "Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes, " Current Drug Metabolism, vol. 3, no. 5, pp. 481-490, 2002.
26. C. Xu, C. Y.-T. Li, and A.-N. T. Kong, "Induction of phase I, II and III drug metabolism/transport by xenobiotics, " Archives of Pharmacal Research, vol. 28, no. 3, pp. 249-268, 2005.
27. J. N. Saykally, L. Rachmany, H. Hatic et al., "The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury, " Neuroscience, vol. 223, pp. 305-314, 2012.
28. W. Jin, J. Kong, H. Wang et al., "Protective effect of tertbutylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice, " Injury, vol. 42, no. 7, pp. 714-718, 2011.
29. F. Nouhi, S. K. Tusi, A. Abdi, and F. Khodagholi, "Dietary supplementation with tBHQ, an NRF2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid-injected rat, " Neurochemical Research, vol. 36, no. 5, pp. 870-878, 2011.
30. A. Alarcón-Aguilar, A. Luna-López, J. L. Ventura-Gallegos et al., "Primary cultured astrocytes from old rats are capable to activate the Nrf2 response against MPP+ toxicity after tBHQ pretreatment, " Neurobiology of Aging, vol. 35, no. 8, pp. 1901-1912, 2014.
31. S. Daniel, J. L. Limson, A. Dairam, G. M. Watkins, and S. Daya, "Through metal binding, curcumin protects against lead-and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain, " Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 266-275, 2004.
32. R. C. Li, S. Z. Guo, S. K. Lee, and D. Gozal, "Neuroglobin protects neurons against oxidative stress in global ischemia, " Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 11, pp. 1874-1882, 2010.
33. P. K. Shukla, V. K. Khanna, M. Y. Khan, and R. C. Srimal, "Protective effect of curcumin against lead neurotoxicity in rat, " Human and Experimental Toxicology, vol. 22, no. 12, pp. 653-658, 2003.
34. T. Rossé, R. Olivier, L. Monney et al., "Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c, " Nature, vol. 391, no. 6666, pp. 496-499, 1998.
35. S. K. Niture and A. K. Jaiswal, "Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance, " Free Radical Biology and Medicine, vol. 57, pp. 119-131, 2013.
36. H. Li, S. Wu, Z. Wang, W. Lin, C. Zhang, and B. Huang, "Neuroprotective effects of tert-butylhydroquinone on paraquatinduced dopaminergic cell degeneration in C57BL/6 mice and in PC12 cells, " Archives of Toxicology, vol. 86, no. 11, pp. 1729-1740, 2012.
37. S. V. Verstraeten, L. Aimo, and P. I. Oteiza, "Aluminium and lead: molecular mechanisms of brain toxicity, " Archives of Toxicology, vol. 82, no. 11, pp. 789-802, 2008.
38. E. A. Hamed, A.-R. M. A. Meki, and N. A. Abd El-Mottaleb, "Protective effect of green tea on lead-induced oxidative damage in rat's blood and brain tissue homogenates, " Journal of Physiology and Biochemistry, vol. 66, no. 2, pp. 143-151, 2010.
39. Y.-M. Zhang, X.-Z. Liu, H. Lu, L. Mei, and Z.-P. Liu, "Lipid peroxidation and ultrastructural modifications in brain after perinatal exposure to lead and/or cadmium in rat pups, " Biomedical and Environmental Sciences, vol. 22, no. 5, pp. 423-429, 2009.
40. B. Halliwell, "Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment, " Drugs and Aging, vol. 18, no. 9, pp. 685-716, 2001.
41. J. M. Matés, C. Pérez-Gómez, and I. N. de Castro, "Antioxidant enzymes and human diseases, " Clinical Biochemistry, vol. 32, no. 8, pp. 595-603, 1999.
42. A. M. Sharifi, S. H. Mousavi, and M. Jorjani, "Effect of chronic lead exposure on pro-apoptotic Bax and anti-apoptotic Bcl-2 protein expression in rat hippocampus in vivo, " Cellular and Molecular Neurobiology, vol. 30, no. 5, pp. 769-774, 2010.
43. A. M. Sharifi and S. H. Mousavi, "Studying the effects of lead onDNAfragmentation and proapoptotic Bax and antiapoptotic Bcl-2 protein expression in PC12 cells, " Toxicology Mechanisms and Methods, vol. 18, no. 1, pp. 75-79, 2008.
44. S. Li, J. Li, C. Shen et al., "tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1841, no. 1, pp. 22-33, 2014.
45. T. Nguyen, P. J. Sherratt, H.-C. Huang, C. S. Yang, and C. B. Pickett, "Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26 S proteasome, " Journal of Biological Chemistry, vol. 278, no. 7, pp. 4536-4541, 2003.
46. J.-I. Lee, J. Kang, and M. H. Stipanuk, "Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation, " Biochemical Journal, vol. 393, no. 1, pp. 181-190, 2006.
47. J.-M. Lee, M. J. Calkins, K. Chan, Y. W. Kan, and J. A. Johnson, "Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis, " Journal of Biological Chemistry, vol. 278, no. 14, pp. 12029-12038, 2003.
48. A. Y. Shih, P. Li, and T. H. Murphy, "A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo, " Journal of Neuroscience, vol. 25, no. 44, pp. 10321-10335, 2005.
49. R. Gozzelino, V. Jeney, and M. P. Soares, "Mechanisms of cell protection by heme oxygenase-1, " Annual Review of Pharmacology and Toxicology, vol. 50, pp. 323-354, 2010.
50. P.-C. Chen, M. R. Vargas, A. K. Pani et al., "Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2933-2938, 2009.
51. P. Wiesel, A. P. Patel, N. DiFonzo et al., "Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice, " Circulation, vol. 102, no. 24, pp. 3015-3022, 2000.
52. X. Zou, J. Gao, Y. Zheng et al., "Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death, " Cell Death and Disease, vol. 5, no. 5, article e1218, 2014.